Acute or Chronic Upregulation of Mitochondrial Fatty Acid Oxidation Has No Net Effect on Whole-Body Energy Expenditure or Adiposity

Cell Metabolism

Volumn 11, Issue 1, 2010, Pages 70-76

  Hoehn, Kyle L ^a,b   Turner, Nigel ^a,c   Swarbrick, Michael M ^a   Wilks, Donna ^a   Preston, Elaine ^a   Phua, Yuwei ^a   Joshi, Himani ^a   Furler, Stuart M ^a   Larance, Mark ^a   Hegarty, Bronwyn D ^a,c   Leslie, Simon J ^a   Pickford, Russell ^c   Hoy, Andrew J ^a   Kraegen, Edward W ^a,c   James, David E ^a,c   Cooney, Gregory J ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

HUMDISEASE

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; GENE MUTATION; LEAN BODY WEIGHT; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; UPREGULATION; WEIGHT REDUCTION;

ACETYL-COA CARBOXYLASE; ADIPOSITY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENERGY METABOLISM; FATTY ACIDS; MICE; MITOCHONDRIA; OXIDATION-REDUCTION; UP-REGULATION;

MUS;

EID: 72649089588     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.11.008     Document Type: Article

References (23)

1. Abu-Elheiga L., Matzuk M.M., Abo-Hashema K.A., and Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291 (2001) 2613-2616
2. Bergeron R., Ren J.M., Cadman K.S., Moore I.K., Perret P., Pypaert M., Young L.H., Semenkovich C.F., and Shulman G.I. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E1340-E1346
3. Bruce C.R., Hoy A.J., Turner N., Watt M.J., Allen T.L., Carpenter K., Cooney G.J., Febbraio M.A., and Kraegen E.W. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58 (2009) 550-558
4. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., and Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458 (2009) 1056-1060
5. Choi C.S., Savage D.B., Abu-Elheiga L., Liu Z.X., Kim S., Kulkarni A., Distefano A., Hwang Y.J., Reznick R.M., Codella R., et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc. Natl. Acad. Sci. USA 104 (2007) 16480-16485
6. Cooney G.J., Lyons R.J., Crew A.J., Jensen T.E., Molero J.C., Mitchell C.J., Biden T.J., Ormandy C.J., James D.E., and Daly R.J. Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J. 23 (2004) 582-593
7. Corbett J.W. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008. Expert. Opin. Ther. Pat. 19 (2009) 943-956
8. Harwood Jr. H.J., Petras S.F., Shelly L.D., Zaccaro L.M., Perry D.A., Makowski M.R., Hargrove D.M., Martin K.A., Tracey W.R., Chapman J.G., et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 278 (2003) 37099-37111
9. Hoy A.J., Bruce C.R., Cederberg A., Turner N., James D.E., Cooney G.J., and Kraegen E.W. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1358-E1364
10. Jäger S., Handschin C., St-Pierre J., and Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 104 (2007) 12017-12022
11. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
12. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J.R., Newgard C.B., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7 (2008) 45-56
13. Lage R., Diéguez C., Vidal-Puig A., and López M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med. 14 (2008) 539-549
14. MacArthur D.G., Seto J.T., Chan S., Quinlan K.G., Raftery J.M., Turner N., Nicholson M.D., Kee A.J., Hardeman E.C., Gunning P.W., et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum. Mol. Genet. 17 (2008) 1076-1086
15. Minkler P.E., Kerner J., Kasumov T., Parland W., and Hoppel C.L. Quantification of malonyl-coenzyme A in tissue specimens by high-performance liquid chromatography/mass spectrometry. Anal. Biochem. 352 (2006) 24-32
16. Narkar V.A., Downes M., Yu R.T., Embler E., Wang Y.X., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 134 (2008) 405-415
17. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., and Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
18. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
19. Reed D.R., Lawler M.P., and Tordoff M.G. Reduced body weight is a common effect of gene knockout in mice. BMC Genet. 9 (2008) 4
20. Savage D.B., Choi C.S., Samuel V.T., Liu Z.X., Zhang D., Wang A., Zhang X.M., Cline G.W., Yu X.X., Geisler J.G., et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J. Clin. Invest. 116 (2006) 817-824
21. Savage D.B., Petersen K.F., and Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 (2007) 507-520
22. Suwa M., Nakano H., and Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 95 (2003) 960-968
23. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., and Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88 (2000) 2219-2226